ShangPharma Corporation

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements and collaborations between companies and academic or other research inst

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Ambrx, NovoCodex To Develop,

Five big investments in health care and life science funds since the end of October delivered more than $1bn in new financing for companies developing biopharmaceuticals and related technology. The ne

Share sales in the pharmaceutical and life science sector in China have been rebounding since March, driven by a string of listings in mainland China and the first initial public offering by a Chinese